{"id":"amyvid-intravenous-solution","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reaction"},{"rate":"null","effect":"Nausea"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amyvid is a radiolabeled ligand that selectively binds to beta-amyloid plaques, allowing for visualization of amyloid burden in the brain. This can aid in the diagnosis of Alzheimer's disease and other neurodegenerative disorders.","oneSentence":"Amyvid is a positron emission tomography (PET) imaging agent that binds to beta-amyloid plaques in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:09:10.949Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnosis of Alzheimer's disease and other neurodegenerative disorders"}]},"trialDetails":[{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT05820191","phase":"PHASE2","title":"B-amyloid as a Marker for GBM Bioimaging","status":"NOT_YET_RECRUITING","sponsor":"Universidad Central del Caribe","startDate":"2024-07","conditions":"Glioblastoma","enrollment":3}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Florbetapir-f18"],"phase":"phase_2","status":"active","brandName":"Amyvid, Intravenous Solution","genericName":"Amyvid, Intravenous Solution","companyName":"Universidad Central del Caribe","companyId":"universidad-central-del-caribe","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amyvid is an intravenous solution used in conjunction with magnetic resonance imaging (MRI) to visualize amyloid beta plaques in the brain. It is an oligosaccharide-based solution, specifically a heparin solution, and has been studied in clinical trials for conditions including Alzheimer Disease and Glioblastoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}